Search

everythinglearnresearchcommunity

for

Search:↓

The decision tree can predict drug absorption issues with good accuracy but needs more validation and adjustments for other factors.

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

Long-term Imiquimod treatment causes initial skin inflammation that lessens over time, and topical corticosteroids reduce this inflammation and cytokines in a mouse model of psoriasis.

The research identified genes linked to male-pattern baldness and potential drug targets for treatment.

Aminoacridine and Abemaciclib, especially combined with Minoxidil, show promise for treating hair loss.

Topical drugs can target hair follicles to treat skin conditions more effectively.

Herbal compounds like ricinoleic acid, quercetin-3-O-rutinoside, and hinokiflavone may be safe and effective for treating hair loss.

Identified genes linked to male-pattern baldness may help develop new treatments.

Some existing drugs and natural products might work against COVID-19 by targeting the virus's main protease.

The regenerative medicine industry saw business growth with new partnerships, clinical trials, and financial investments.

Using computers to analyze drugs can find new uses for them, but actual experiments are needed to confirm these uses.

Old drugs like finasteride and spironolactone are being successfully used for hair loss and skin conditions, and many other drugs show promise for new uses in dermatology.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

Advanced human skin models improve drug development and could replace animal testing.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

The document concludes that there is no agreed-upon best method for measuring drug delivery within hair follicles and more research is needed to validate current techniques.

Finding new uses for existing drugs is promising and can lead to safer, more effective medicines.

Using old drugs for new uses can help treat rare immune deficiencies.

The conclusion is that measuring how drugs partition into artificial sebum is important for predicting their delivery into hair and sebaceous follicles, and it provides better information than traditional methods.

DrugNet effectively identifies new uses for existing drugs and may save resources in drug development.

Dermal papilla microtissues could be useful for initial hair growth drug testing.

The anti-viral drug Elvitegravir may protect brain cells from damage related to neurodegenerative diseases.

New targeted therapies for hair loss from alopecia areata show promise, with personalized treatment expected in the future.

Computational tools identified 29 drugs that could potentially target 19 genes involved in chemotherapy-induced hair loss, which could lead to more effective treatments.

Most drugs fail to reach the market, but understanding their properties and using strategies like early toxicity tests and drug repurposing can help advance their development.

The study concludes that certain domains in Clostridium histolyticum enzymes are structurally unique, bind calcium to become more stable, and play distinct roles in breaking down collagen, with potential applications in medicine and drug delivery.

Decursin shows promise for treating cancer, neuroprotection, inflammation, and hair loss.